Market-Price Risk on Investment Securities
First written in FY2019. 4 of 9 entries say "Mitigated", first in FY2023-Q1. Latest entry: FY2024.
The whole theme swung hardest in 2019: 64 of 141 companies on the "Worse" side.
54 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「There were no applicable matters during the fiscal year.」
There was no impairment of investment securities during the fiscal year, and no impairment loss attributable to fluctuations in market prices was identified. - FY2023MitigatedAnnual report
「There were no applicable matters during the fiscal year.」
The Company stated that there was no impairment of other securities during the fiscal year, compared with ¥1.865 million recorded in the previous fiscal year. No impairment loss attributable to market price fluctuation risk was identified for the full fiscal year. - FY2023-Q3MitigatedAnnual report
「Impairment loss on investment securities 1,595 －」
The ¥1.595 million impairment loss on investment securities recorded during the cumulative period of the previous third quarter was not recorded during the cumulative third quarter. - FY2023-Q1MitigatedAnnual report
「Impairment loss on investment securities 1,490 －」
The ¥1.490 million impairment loss on investment securities recorded in the same quarter of the previous year was not recorded during the cumulative first quarter. No impairment loss attributable to market price fluctuation risk was identified for the quarter. - FY2022-Q3MaterialisedAnnual report
「Impairment loss on investment securities － 1,595」
An impairment loss on investment securities of ¥1.595 million was recorded during the cumulative third quarter. No such loss was recorded during the cumulative third quarter of the previous fiscal year, and impairment losses on investment securities continue to arise. - FY2022-Q2MaterialisedAnnual report
「Impairment loss on investment securities － 1,505」
An impairment loss on investment securities of ¥1.505 million was recorded during the cumulative second quarter. No such loss was recorded during the cumulative second quarter of the previous fiscal year, and impairment losses related to fluctuations in the market prices of investment securities continue to arise. - FY2022-Q1MaterialisedAnnual report
「Impairment loss on investment securities － 1,490」
An impairment loss on investment securities of ¥1.490 million was recorded in the first quarter. Although the main text does not identify a causal relationship with market price fluctuation risk, an impairment loss on investment securities was incurred. - FY2021RestatedAnnual report
「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to market-price fluctuation risk.」
Market price fluctuation risk relating to investment securities, mainly shares of companies with which the Company has business relationships, continues to be disclosed. - FY2019First statedAnnual report
「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to market-price fluctuation risk.」
For investment securities, mainly shares of companies with which the Company has business relationships, market price fluctuation risk was described for the first time as a separate financial instrument risk.